GO	[-22.20 -0.51]	[-0.51 -0.28]	[-0.28 -0.16]	[-0.16 -0.07]	[-0.07 0.00]	[0.00 0.04]	[0.04 0.14]	[0.14 0.26]	[0.26 0.48]	[0.48 0.94]	[0.94 24.36]
HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_7DY_UP HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_7DY_UP	-0.471	-1.259	-1.259	-2.031	4.105	6.163	-2.031	-2.031	-0.270	0.546	-0.475
NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_DN NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_DN	1.961	0.233	-1.501	-2.322	0.613	4.002	-1.501	-2.322	-2.322	-0.381	2.399
FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN	-0.382	-0.647	-0.647	-2.695	-0.821	-3.783	-0.821	-1.028	2.737	3.731	4.444
ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_NEGATIVE ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_NEGATIVE	3.801	-1.304	-1.740	-3.034	0.269	4.771	-1.740	-1.740	-0.696	0.399	1.500
THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_UP THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_UP	-3.337	-0.423	0.421	-0.301	2.255	-1.023	5.042	1.653	-1.023	-1.323	-2.145
SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENT_SUBJECTS_1DY_UP SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENT_SUBJECTS_1DY_UP	2.692	-0.925	-0.524	-1.616	-1.616	0.320	-0.925	-1.616	-0.524	1.658	3.277
SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_CORRELATED_WITH_TRANSITIONAL_B_CELLS_UP SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_CORRELATED_WITH_TRANSITIONAL_B_CELLS_UP	1.437	-0.870	-0.378	-0.870	-0.870	0.236	-0.870	-0.870	-0.870	0.527	5.277
HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP	2.638	1.283	0.429	-2.545	-1.383	-1.710	-1.106	-0.678	-1.106	1.071	2.945
KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE	1.865	-0.354	0.453	-1.782	0.453	0.716	-1.782	-1.782	-1.782	1.041	1.418
FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_UP FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_UP	2.035	-0.854	-1.177	-1.177	-1.593	1.389	-1.593	-0.854	-0.606	1.389	3.203
FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_UP FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_UP	4.583	-0.423	-1.323	-1.689	-1.023	0.564	-1.323	-1.023	-0.580	1.386	1.639
HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP	-0.910	1.378	1.064	3.016	0.561	-0.389	0.561	-0.606	-1.332	-1.332	-2.831
THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_UP THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_UP	-3.555	0.285	0.788	0.383	1.363	-0.557	3.344	0.634	-0.425	-0.718	-2.516
HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN	4.374	0.502	-0.318	-0.318	-1.699	-0.574	-1.699	-0.318	-0.991	-0.318	1.529
ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN	-2.549	0.290	-0.313	-0.473	0.616	-0.691	3.277	1.084	1.370	-1.364	-1.878
GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_DN GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_DN	0.784	-1.168	-1.488	-0.687	-0.512	-0.687	-0.373	-0.373	-1.488	2.631	4.132
NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_ATIV_UP NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_ATIV_UP	2.072	0.302	1.596	-0.958	-0.958	-1.658	-0.549	-1.658	-0.549	1.178	0.816
ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_3DY_DN ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_3DY_DN	-1.409	-1.409	-1.409	-0.764	0.216	1.514	3.196	0.427	0.427	0.216	-0.410
LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_POSITIVE LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_POSITIVE	-0.283	-0.524	-0.524	-1.616	0.859	-0.925	-0.925	-0.283	-0.925	2.147	3.277
HOFT_PBMC_TICE_BCG_RBCG_AG85A_AG85B_AGE_18_40YO_CORRELATED_WITH_WHOLE_BLOOD_BACTERICIDAL_ACTIVITY_NEGATIVE HOFT_PBMC_TICE_BCG_RBCG_AG85A_AG85B_AGE_18_40YO_CORRELATED_WITH_WHOLE_BLOOD_BACTERICIDAL_ACTIVITY_NEGATIVE	0.528	0.302	0.302	-1.658	-0.958	-0.300	-1.658	0.302	-0.958	0.821	3.807
KENNEDY_PBMC_DRYVAX_AGE_18_40YO_STIMULATED_VS_UNSTIMULATED_1_TO_48MO_TOP_DEG_DN KENNEDY_PBMC_DRYVAX_AGE_18_40YO_STIMULATED_VS_UNSTIMULATED_1_TO_48MO_TOP_DEG_DN	0.681	-0.796	-0.430	-1.450	-0.430	-0.430	-1.450	-0.796	0.403	1.936	3.075
ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP	0.320	0.859	0.555	-0.524	0.859	3.290	-0.925	-1.616	-1.616	-0.925	-0.285
HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_28DY_DN HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_28DY_DN	-0.762	0.302	-0.762	-1.713	-0.762	-1.152	0.702	-0.762	-0.300	3.470	2.468
HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_DN HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_DN	1.862	0.985	-0.828	-0.828	-0.828	-0.234	-0.828	-1.492	-0.828	0.381	2.970
LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_POSITIVE LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_POSITIVE	-0.260	-0.691	-0.260	-2.447	-0.434	-0.691	-0.691	-0.691	0.542	2.682	2.669
QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DYAT_1DY_NEGATIVE QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DYAT_1DY_NEGATIVE	-2.271	-1.593	2.757	0.738	-0.325	-1.318	0.278	0.278	2.468	0.368	-0.884
QI_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_ZOSTAVAX_AGE_52_75YO_CD4_T_CELL_VS_NAIVE_CD4_T_CELL_7_TO_9DY_DN QI_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_ZOSTAVAX_AGE_52_75YO_CD4_T_CELL_VS_NAIVE_CD4_T_CELL_7_TO_9DY_DN	-0.373	-0.373	-0.373	-0.373	1.382	4.435	-0.373	-0.373	-0.373	-0.373	-0.374
QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_UP QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_UP	0.921	3.799	0.921	0.626	-0.411	-0.228	-1.157	-1.157	-1.157	-1.157	-0.706
QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_7DY_UP QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_7DY_UP	0.921	3.799	0.921	0.626	-0.411	-0.228	-1.157	-1.157	-1.157	-1.157	-0.706
PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGED_POST_VACCINATION_VS_UNCHALLENGED_72HR_TOP_30_DEG_UP PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGED_POST_VACCINATION_VS_UNCHALLENGED_72HR_TOP_30_DEG_UP	-0.610	0.303	0.303	-1.201	-0.610	0.929	-1.201	-0.610	-0.299	-0.299	4.593
ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GTE_200_VS_LTE_200_1DY_UP ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GTE_200_VS_LTE_200_1DY_UP	0.318	0.693	-1.625	-1.064	0.549	5.499	0.318	-0.662	-1.322	-0.385	-0.516
LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_CORRELATED_WITH_ANTIBODY_RESPONSE_3DY_NEGATIVE LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_CORRELATED_WITH_ANTIBODY_RESPONSE_3DY_NEGATIVE	0.398	-1.035	-0.491	-1.035	0.398	-1.035	-0.222	-1.035	0.398	1.150	2.910
THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_UP THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_UP	-2.134	0.684	0.884	0.884	1.367	-1.262	0.884	0.512	0.684	-2.134	-1.660
OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP	-3.231	0.349	2.233	-0.360	1.663	-0.490	-0.360	1.178	-0.258	-0.490	-1.745
QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_28D_PEAK_T_CELL_RESPONSE_14DY_NEGATIVE QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_28D_PEAK_T_CELL_RESPONSE_14DY_NEGATIVE	-0.250	0.941	2.307	0.941	-0.476	-0.860	0.359	0.615	-0.860	-1.533	-1.539
ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_POSITIVE ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_POSITIVE	-1.804	-0.289	-0.652	1.146	1.443	-0.442	1.773	-0.934	0.468	0.658	-2.485
HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_1DY_UP HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_1DY_UP	-0.538	-0.176	-0.538	-0.538	-0.176	5.413	-0.176	-0.538	-0.176	-0.538	-0.177
VOIGT_PBMC_FLUARIX_AGE_50_74YO_FEMALES_VS_MALES_0DY_TO_28D_UP VOIGT_PBMC_FLUARIX_AGE_50_74YO_FEMALES_VS_MALES_0DY_TO_28D_UP	2.150	-0.828	0.566	-0.828	0.256	-0.828	-0.828	-0.351	-0.351	-0.351	2.144
HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN	0.703	-0.493	0.528	-1.238	-0.930	-2.708	0.380	-0.930	0.528	1.398	2.321
QI_NAIVE_T_CELL_ZOSTAVAX_AGE_52_75YO_CD4_T_CELL_VS_NAIVE_CD4_T_CELL_7_TO_9DY_DN QI_NAIVE_T_CELL_ZOSTAVAX_AGE_52_75YO_CD4_T_CELL_VS_NAIVE_CD4_T_CELL_7_TO_9DY_DN	-0.290	-0.290	-0.290	-0.290	0.313	5.444	-0.290	-0.290	-0.290	-0.290	-0.291
NAKAYA_PBMC_FLUAD_IMUVAC_MALE_AGE_14_27YO_CORRELATED_WITH_HAI_RESPONSE_MF59_ADJUVANTED_AND_NON_1DY_GENES_IN_BTM_M75_POSITIVE NAKAYA_PBMC_FLUAD_IMUVAC_MALE_AGE_14_27YO_CORRELATED_WITH_HAI_RESPONSE_MF59_ADJUVANTED_AND_NON_1DY_GENES_IN_BTM_M75_POSITIVE	0.279	3.861	0.609	0.279	0.279	-0.324	-0.787	-0.787	-0.787	-0.324	-0.789
ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GT_200_VS_LTE_200_1DY_DN ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GT_200_VS_LTE_200_1DY_DN	0.544	0.393	-2.072	-0.909	-0.479	-0.334	-0.909	-0.668	0.393	0.544	4.437
MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_2DY_UP MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_2DY_UP	-0.566	0.405	-0.359	-0.859	-1.271	0.250	-0.359	-1.271	-0.566	3.159	2.224
ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_UP ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_UP	-1.029	-0.730	-0.505	-1.934	0.267	3.150	-0.338	0.267	-0.505	1.948	0.264
QI_NAIVE_T_CELL_ZOSTAVAX_AGE_52_75YO_CD4_T_CELL_VS_NAIVE_CD4_T_CELL_7_TO_9DY_UP QI_NAIVE_T_CELL_ZOSTAVAX_AGE_52_75YO_CD4_T_CELL_VS_NAIVE_CD4_T_CELL_7_TO_9DY_UP	-0.248	-0.248	-0.248	-0.248	1.014	3.057	-0.248	-0.248	-0.248	-0.248	-0.249
